-
Je něco špatně v tomto záznamu ?
circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks
R. Drula, R. Pirlog, M. Trif, O. Slaby, C. Braicu, I. Berindan-Neagoe
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- genové regulační sítě * MeSH
- kruhová RNA genetika MeSH
- lidé MeSH
- messenger RNA genetika metabolismus MeSH
- mikro RNA genetika MeSH
- nádory genetika patologie MeSH
- regulace genové exprese u nádorů * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Circular RNAs (circRNA) have gained recent interest due to their functional versatility due to their interactions with other RNA species and proteins, all of which underline complex regulatory networks involved in pathogenic mechanisms. As a result, recent insights in circRNA biology are investigating their biomarker and therapeutic potential. One such circRNA is CircFOXO3, which consists of the circularized second exon of the FOXO3 mRNA, a member of the forkhead box transcription factor family involved in the regulation of developmental programs. Recent research focused on the role of circFOXO3 in the context of cancer has highlighted several implications in key tumorigenesis mechanisms, thus consolidating its relevance among other identified circRNAs. In this paper, we will focus on the currently identified case-specific implications of circFOXO3 in cancer, with a focus on the circFOXO3-miRNA-mRNA regulatory networks, its interactions with different proteins, and their cumulated biological effects upon tumor development. Therefore, we aim to provide an integrated perspective of the mechanistic implications of circFOXO3 in different cancers while also highlighting its biomarker or therapeutic potential based on the current evidence.
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025763
- 003
- CZ-PrNML
- 005
- 20211026133534.0
- 007
- ta
- 008
- 211013s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbadis.2020.166045 $2 doi
- 035 __
- $a (PubMed)33513429
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Drula, Rares $u Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Electronic address: drula.rares@gmail.com
- 245 10
- $a circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks / $c R. Drula, R. Pirlog, M. Trif, O. Slaby, C. Braicu, I. Berindan-Neagoe
- 520 9_
- $a Circular RNAs (circRNA) have gained recent interest due to their functional versatility due to their interactions with other RNA species and proteins, all of which underline complex regulatory networks involved in pathogenic mechanisms. As a result, recent insights in circRNA biology are investigating their biomarker and therapeutic potential. One such circRNA is CircFOXO3, which consists of the circularized second exon of the FOXO3 mRNA, a member of the forkhead box transcription factor family involved in the regulation of developmental programs. Recent research focused on the role of circFOXO3 in the context of cancer has highlighted several implications in key tumorigenesis mechanisms, thus consolidating its relevance among other identified circRNAs. In this paper, we will focus on the currently identified case-specific implications of circFOXO3 in cancer, with a focus on the circFOXO3-miRNA-mRNA regulatory networks, its interactions with different proteins, and their cumulated biological effects upon tumor development. Therefore, we aim to provide an integrated perspective of the mechanistic implications of circFOXO3 in different cancers while also highlighting its biomarker or therapeutic potential based on the current evidence.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 12
- $a genové regulační sítě $7 D053263
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a nádory $x genetika $x patologie $7 D009369
- 650 _2
- $a kruhová RNA $x genetika $7 D000079962
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pirlog, Radu $u Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Electronic address: pirlog.radu@yahoo.com
- 700 1_
- $a Trif, Monica $u Centiv DE, Bremen, Germany. Electronic address: mt@centiv.de
- 700 1_
- $a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic. Electronic address: on.slaby@gmail.com
- 700 1_
- $a Braicu, Cornelia $u Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Electronic address: cornelia.braicu@umfcluj.ro
- 700 1_
- $a Berindan-Neagoe, Ioana $u Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Functional Genomics and Experimental Pathology, "Prof. Dr. Ion Chiricuta" Oncology Institute, Cluj-Napoca, Romania. Electronic address: ioana.neagoe@umfcluj.ro
- 773 0_
- $w MED00000539 $t Biochimica et biophysica acta. Molecular basis of disease $x 1879-260X $g Roč. 1867, č. 5 (2021), s. 166045
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33513429 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133540 $b ABA008
- 999 __
- $a ok $b bmc $g 1714686 $s 1146270
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 1867 $c 5 $d 166045 $e 20210126 $i 1879-260X $m Biochimica et biophysica acta. Molecular basis of disease $n Biochim Biophys Acta $x MED00000539
- LZP __
- $a Pubmed-20211013